Polzer

Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health

Retrieved on: 
Monday, October 18, 2021

Zoetis Inc. (NYSE:ZTS) today announced the appointment of Robert J. Polzer, PhD, as Executive Vice President and President of Research & Development for the company, effective Jan. 1, 2022.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) today announced the appointment of Robert J. Polzer, PhD, as Executive Vice President and President of Research & Development for the company, effective Jan. 1, 2022.
  • Knupp plans to retire after a remarkable career of building the organizational talent and capabilities that have made Zoetis the innovative leader in animal health.
  • Zoetis and the animal health industry -- owe Cathy Knupp a huge debt of gratitude for the way she has influenced innovation in animal health and veterinary care during her tenure at Zoetis and Pfizer Animal Health, said Zoetis CEO Kristin Peck.
  • Before joining Zoetis, Knupp served as Vice President of Veterinary Medicine, Research & Development for Pfizer Animal Health for eight years, beginning in 2005.